Objective To analyze the clinical characteristics of myositis autoantibody detection in the
diagnosis of interstitial lung disease (ILD), and explore the diagnosis and treatment of ILD …

Interstitial lung disease (ILD) is an extramuscular manifestation associated with increased
mortality in idiopathic inflammatory myopathy (IIM). To identify risk factors for ILD in patients …

Objective To identify immunologic factors in the lungs of patients with rheumatoid arthritis–
associated interstitial lung disease (RA‐ILD) and patients with idiopathic inflammatory …

Background Interstitial lung disease (ILD) is the most common internal organ manifestation
of idiopathic inflammatory myopathies (IIM) that can severely affect the course of the …

Inflammatory myopathies (IM) are auto-immune connective tissue diseases characterized by
muscle involvement and by extramuscular manifestations. As such, pulmonary …

Objectives Interstitial lung disease (ILD) is one of the common extramuscular involvement in
idiopathic inflammatory myopathies (IIMs)(1). Several patients develop a progressive …

PURPOSE: Interstitial lung disease (ILD) is a frequent manifestation and major cause of
morbidity and mortality for patients with idiopathic interstitial myositis (IIM). Up to 30% of the …

Background Idiopathic inflammatory myopathy (IIM) is a group of connective tissue diseases
characterized by muscle inflammation and muscle weakness, lung involvement is an …

Purpose: To perform a semiquantitative and quantitative analysis of interstitial lung disease
(ILD), through computed tomography (CT), in different serological subgroups of idiopathic …

Objective: To investigate the clinical significance of detection of myositis-specific antibodies
(MSAs) and myositis-associated antibodies (MAAs) in patients with connective tissue …